ACTRN12622001509752招募中未知
COVAXI - 2: SARS-CoV-2 vaccination and the immune responses in patients with haematological malignancy and other immune deficiency.
The Perth Blood Institute0 个研究点目标入组 450 人开始时间: 2022年12月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Age > or = 18.
- •Are eligible to receive or have received at least 3 doses of the standard of care SARS-COV-2 vaccine as per current Australian Government Therapeutic Goods Administration Vaccine Guidelines. Currently in Australia vaccines choices include Astra Zeneca (ChAdOx1), Pfizer (BNT162b2) Moderna (mRNA -1273) and Novavax.
- •Patients with haematology disorders including CLL (Chronic lymphocytic leukemia), lymphoma, other B cell lymphoproliferative disorders, myeloma, MGUS (Monoclonal gammopathy of undetermined significance), myeloproliferative disorders and other immunosuppressed patients.
- •Patients who present to primary care without haematological disorders who have received at least 3 doses of SARS-COV-2 vaccination according to Australian Government Vaccine Guidelines.
- •Able and willing to provide Written and Informed Consent.
排除标准
- •People with vaccine allergies.
- •Pregnant or breast-feeding woman.
研究者
相似试验
已完成
不适用
Immune response against SARS-CoV-2 vaccinatioCOVID-19DRKS00028174DKFZ6
已完成
Unknown
Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients on Disease-Modifying DrugsMultiple SclerosisJPRN-UMIN000049478Osaka University Department of Neurology, Osaka University Graduate School of Medicine50
进行中（未招募）
1 期
SARS-Cov-2 vaccine responsiveness in middle-aged and older personsSARS-CoV-19, frailtyEUCTR2021-001976-40-NLational Institute for Public Health and the Environment1,700
招募中
4 期
Monitoring immunogenicity of SARS-Cov-2 vaccination in Dutch middle-aged and older individuals (participating in the Doetinchem Cohort Study)NL-OMON54058Ministerie van Volksgezondheid, Welzijn en Sport (VWS)1,700
已完成
4 期
SARS-CoV2 vaccination and activation of the coagulation systemcovid-19thrombosis1004743810014523NL-OMON51038Academisch Medisch Centrum40